P

Panaxia Labs Israel Ltd
TASE:PNAX

Watchlist Manager
Panaxia Labs Israel Ltd
TASE:PNAX
Watchlist
Price: 5 192 ILS -1.05%
Market Cap: 7.9m ILS
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

PNAX Price Targets Summary
Panaxia Labs Israel Ltd

There are no price targets for PNAX.
PNAX Lowest Forecast
Wall Street Target
Not Available
PNAX Average Forecast
Wall Street Target
Not Available
PNAX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Panaxia Labs Israel Ltd Competitors:
Price Targets
NOVN
Novartis AG
10% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
21% Upside
000538
Yunnan Baiyao Group Co Ltd
23% Upside
NEULANDLAB
Neuland Laboratories Ltd
34% Upside
NOVN
Novartis AG
10% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
21% Upside
000538
Yunnan Baiyao Group Co Ltd
23% Upside
NEULANDLAB
Neuland Laboratories Ltd
34% Upside
AZN
AstraZeneca PLC
27% Upside
600085
Beijing Tongrentang Co Ltd
18% Upside
VY4
SNDL Inc
192% Upside

Revenue
Forecast

Revenue Estimate
Panaxia Labs Israel Ltd

Revenue forecast
is not available for
Panaxia Labs Israel Ltd

Operating Income
Forecast

Operating Income Estimate
Panaxia Labs Israel Ltd

Operating Income forecast
is not available for
Panaxia Labs Israel Ltd

Net Income
Forecast

Net Income Estimate
Panaxia Labs Israel Ltd

Net Income forecast
is not available for
Panaxia Labs Israel Ltd

See Also

Summary
PNAX intrinsic value, competitors valuation, and company profile.
DCF Valuation
PNAX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PNAX stock valuation using valuation multiples.
Wall Street Estimates
PNAX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PNAX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PNAX's stock price target?
Not Available

PNAX doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.